Premature ovarian insufficiency
Conditions
Interventions
None listed
Sponsors
Gunma university hospital
Akita University Graduate School of Medicine ,Department of Obstetrics and Gynecology Asada Ladies Clinic Kansai Medical University Hospital, Department of Obstetrics and Gynecology Keio University School of Medicine ,Department of Obstetrics and Gynecology Saitama Medical School Hospital ,Department of Obstetrics and Gynecology Saitama Medical School General Medical Center ,Department of Obstetrics and Gynecology Jichi Medical University ,Department of Obstetrics and Gynecology Shimane U
s Medicine and Surgery Toho University Medical Center Omori Hospital ,Department of Obstetrics and Gynecology Tokushima University Hospital ,Department of Obstetrics and Gynecology Nagasaki University Hospital ,Department of Obstetrics and Gynecology Hyogo University of Medical Science ,Department of Obstetrics and Gynecology
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1) Patients who started their first IVF/ICSI treatment cycle between January 1, 2021 and December 31, 2021.(The start date of the treatment cycle is the start date of regulated ovarian stimulation, or the start date of menstruation in the case of natural cycles.) 2) Patients whose AMH concentration is less than 1.1 ng/mL within 6 months prior to IVF/ICSI treatment.
Exclusion criteria
Exclusion criteria: Patients who are deemed inappropriate for inclusion in the program by a physician's judgment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy rate per IVF/ICSI treatment cycle by cause of POI | — |
Secondary
| Measure | Time frame |
|---|---|
| Type of fertility drugs, dosage, number of eggs retrieved, number of fertilized eggs, number of embryos transferred, embryo grade, production rate | — |
Countries
Japan
Contacts
Public ContactAkira Iwase
Department of Gunma university hospital Obstetrics & Gynecology
Outcome results
None listed